Enes Erul
Impact in
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 9
- Inflammatory Biomarkers in Disease Prognosis 5
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 detection and testing 2
- Co-authors
- Deniz Can Güven (18 shared papers)Taha Koray Şahin (15 shared papers)Sercan Aksoy (13 shared papers)Saadettin Kılıçkap (6 shared papers)Alessandro Rizzo (3 shared papers)Şuayib Yalçın (6 shared papers)Thilo Gambichler (1 shared paper)Angela Dalia Ricci (2 shared papers)
- Journals
- Vaccines (4 papers)Critical Reviews in Oncology/Hematology (2 papers)Supportive Care in Cancer (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)Journal of Clinical Medicine (1 paper)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Enes Erul
27 papers receiving 607 citations
Enes Erul's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 304
- Virology 37
- Otorhinolaryngology 30
- Cancer Research 87
- Pulmonary and Respiratory Medicine 155
Countries citing papers authored by Enes Erul
This map shows the geographic impact of Enes Erul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enes Erul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enes Erul more than expected).
Fields of papers citing papers by Enes Erul
This network shows the impact of papers produced by Enes Erul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enes Erul. The network helps show where Enes Erul may publish in the future.
Co-authors
The 25 scholars most cited alongside Enes Erul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis Hit paper breakdown → | 2022 | 138 |
| 2 | 2022 | 131 | |
| 3 | Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data Hit paper breakdown → | 2023 | 104 |
| 4 | 2022 | 39 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 21 | |
| 8 | 2023 | 20 | |
| 9 | 2024 | 19 | |
| 10 | 2023 | 19 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2025 | 3 |
About Enes Erul
Enes Erul is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine, having authored 34 papers that have together received 610 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), COVID-19 Clinical Research Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Head and Neck Cancer Studies (3 papers), SARS-CoV-2 detection and testing (2 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Oncology (304 citations), Virology (37 citations), Otorhinolaryngology (30 citations), Cancer Research (87 citations) and Pulmonary and Respiratory Medicine (155 citations). Enes Erul has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Deniz Can Güven, Taha Koray Şahin, Sercan Aksoy, Saadettin Kılıçkap, Alessandro Rizzo, Şuayib Yalçın, Thilo Gambichler, Angela Dalia Ricci, Raffaele De Luca and Baran Akagündüz. Their work appears in journals such as Vaccines, Critical Reviews in Oncology/Hematology, Supportive Care in Cancer, European Archives of Oto-Rhino-Laryngology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.